Search for: "Blood Systems Inc" Results 201 - 220 of 794
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Oct 2018, 11:21 am by John Elwood
(relisted after the October 26 conference)   AT&T, Inc v. [read post]
26 Oct 2018, 10:16 am by Kelsey M. Mackin
 Use or consumption of this product may elevate lead levels in the blood. [read post]
26 Oct 2018, 2:00 am by Ed Muzio, CEO, Group Harmonics
If the pace is too fast or the surface too difficult, the muscles will need more oxygen in the blood, and the request will be raised through the nervous system. [read post]
26 Oct 2018, 2:00 am by Ed Muzio, CEO, Group Harmonics
If the pace is too fast or the surface too difficult, the muscles will need more oxygen in the blood, and the request will be raised through the nervous system. [read post]
24 Oct 2018, 9:03 pm by Kelsey M. Mackin
“The product sampling was conducted as a result of a consumer complaint regarding elevated blood lead levels in a child,” the recall notice said. [read post]
16 Aug 2018, 10:05 am by Jeffrey P. Gale, P.A.
Employees testing positive for alcohol or drugs in their system at the time of injury face an uphill battle to recover workers’ compensation benefits. [read post]
22 Jul 2018, 9:00 pm by Cookson Beecher
High risk groups more likely to develop life-threatening illnesses are young children, pregnant women, old people, and other people with compromised immune systems, among them are cancer patients, HIV-positive patients, and transplant recipients. [read post]
1 Jun 2018, 8:23 am by Eugene Volokh
—on behalf of the International Society for Krishna Consciousness, Inc.; here is the heart of our argument, which I think largely coincides with the court's: Summary of Argument When Covenant Reformed Church described the lead plaintiffs' conduct as adulterous, it was expressing a moral evaluation of uncontested facts—an opinion based on those facts. [read post]
27 Apr 2018, 3:33 pm by David Jensen
Updates on the status of CIRM research can also be found as it progresses by searching on the application number.Sangamo Therapeutics, Inc., of Richmond, Ca., was awarded $8 million to "test a new therapy (phase one/two) for beta-thalassemia, a severe form of anemia (lack of healthy red blood cells) caused by mutations in the beta hemoglobin gene. [read post]